HALEON PLC-ADR (HLN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:HLN - US4055521003 - ADR
10.04 USD
-0.01 (-0.1%)
9.98 USD
-0.06 (-0.6%)
Taking everything into account, HLN scores 6 out of 10 in our fundamental rating. HLN was compared to 191 industry peers in the Pharmaceuticals industry. While HLN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. HLN has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
HLN had positive earnings in the past year.
In the past year HLN had a positive cash flow from operations.
In the past 5 years HLN has always been profitable.
Each year in the past 5 years HLN had a positive operating cash flow.
1.2 Ratios
HLN has a better Return On Assets (4.20%) than 85.34% of its industry peers.
HLN has a Return On Equity of 8.92%. This is amongst the best in the industry. HLN outperforms 84.29% of its industry peers.
HLN has a better Return On Invested Capital (6.11%) than 83.77% of its industry peers.
The Average Return On Invested Capital over the past 3 years for HLN is significantly below the industry average of 12.85%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.2% | ||
| ROE | 8.92% | ||
| ROIC | 6.11% |
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
1.3 Margins
HLN's Profit Margin of 12.84% is amongst the best of the industry. HLN outperforms 85.34% of its industry peers.
HLN's Profit Margin has improved in the last couple of years.
The Operating Margin of HLN (21.31%) is better than 89.01% of its industry peers.
In the last couple of years the Operating Margin of HLN has grown nicely.
HLN's Gross Margin of 60.75% is fine compared to the rest of the industry. HLN outperforms 70.68% of its industry peers.
In the last couple of years the Gross Margin of HLN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.31% | ||
| PM (TTM) | 12.84% | ||
| GM | 60.75% |
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
HLN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, HLN has less shares outstanding
HLN has less shares outstanding than it did 5 years ago.
HLN has a worse debt/assets ratio than last year.
2.2 Solvency
HLN has an Altman-Z score of 2.31. This is not the best score and indicates that HLN is in the grey zone with still only limited risk for bankruptcy at the moment.
HLN has a Altman-Z score of 2.31. This is in the better half of the industry: HLN outperforms 60.73% of its industry peers.
HLN has a debt to FCF ratio of 5.11. This is a neutral value as HLN would need 5.11 years to pay back of all of its debts.
HLN has a better Debt to FCF ratio (5.11) than 82.20% of its industry peers.
A Debt/Equity ratio of 0.53 indicates that HLN is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.53, HLN is doing worse than 64.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 5.11 | ||
| Altman-Z | 2.31 |
ROIC/WACC0.75
WACC8.15%
2.3 Liquidity
HLN has a Current Ratio of 0.98. This is a bad value and indicates that HLN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of HLN (0.98) is worse than 85.34% of its industry peers.
A Quick Ratio of 0.78 indicates that HLN may have some problems paying its short term obligations.
HLN has a worse Quick ratio (0.78) than 84.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.78 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 6.59% over the past year.
HLN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.56% yearly.
Looking at the last year, HLN shows a decrease in Revenue. The Revenue has decreased by -0.61% in the last year.
Measured over the past years, HLN shows a small growth in Revenue. The Revenue has been growing by 5.78% on average per year.
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-5.33%
3.2 Future
The Earnings Per Share is expected to grow by 10.10% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.76% on average over the next years.
EPS Next Y5.74%
EPS Next 2Y8.04%
EPS Next 3Y8.69%
EPS Next 5Y10.1%
Revenue Next Year-1.32%
Revenue Next 2Y1.63%
Revenue Next 3Y2.58%
Revenue Next 5Y3.76%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 20.08 indicates a rather expensive valuation of HLN.
Based on the Price/Earnings ratio, HLN is valued cheaply inside the industry as 80.10% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.00, HLN is valued a bit cheaper.
With a Price/Forward Earnings ratio of 17.35, HLN is valued on the expensive side.
Based on the Price/Forward Earnings ratio, HLN is valued a bit cheaper than the industry average as 79.58% of the companies are valued more expensively.
HLN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.70.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.08 | ||
| Fwd PE | 17.35 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, HLN is valued cheaper than 82.20% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, HLN is valued cheaper than 85.34% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.78 | ||
| EV/EBITDA | 15.14 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HLN does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of HLN may justify a higher PE ratio.
PEG (NY)3.5
PEG (5Y)1.14
EPS Next 2Y8.04%
EPS Next 3Y8.69%
5. Dividend
5.1 Amount
HLN has a Yearly Dividend Yield of 1.81%. Purely for dividend investing, there may be better candidates out there.
HLN's Dividend Yield is rather good when compared to the industry average which is at 0.42. HLN pays more dividend than 92.67% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.94, HLN has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.81% |
5.2 History
HLN has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of HLN decreased recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
39.53% of the earnings are spent on dividend by HLN. This is a low number and sustainable payout ratio.
DP39.53%
EPS Next 2Y8.04%
EPS Next 3Y8.69%
10.04
-0.01 (-0.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners58.32%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap44.71B
Revenue(TTM)11.23B
Net Income(TTM)1.44B
Analysts79.17
Price Target11.45 (14.04%)
Short Float %0.32%
Short Ratio1.51
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.81% |
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP39.53%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.58%
Min EPS beat(2)-1.92%
Max EPS beat(2)7.08%
EPS beat(4)3
Avg EPS beat(4)3.76%
Min EPS beat(4)-1.92%
Max EPS beat(4)7.54%
EPS beat(8)4
Avg EPS beat(8)-10.37%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.51%
Min Revenue beat(2)-5.38%
Max Revenue beat(2)-1.64%
Revenue beat(4)0
Avg Revenue beat(4)-3.11%
Min Revenue beat(4)-5.38%
Max Revenue beat(4)-1.64%
Revenue beat(8)1
Avg Revenue beat(8)-2.55%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.24%
PT rev (3m)-0.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.04%
EPS NY rev (1m)0.04%
EPS NY rev (3m)0.53%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.08 | ||
| Fwd PE | 17.35 | ||
| P/S | 2.96 | ||
| P/FCF | 16.78 | ||
| P/OCF | 14.46 | ||
| P/B | 2.06 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.14 |
EPS(TTM)0.5
EY4.98%
EPS(NY)0.58
Fwd EY5.76%
FCF(TTM)0.6
FCFY5.96%
OCF(TTM)0.69
OCFY6.92%
SpS3.39
BVpS4.88
TBVpS-3.03
PEG (NY)3.5
PEG (5Y)1.14
Graham Number7.41
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.2% | ||
| ROE | 8.92% | ||
| ROCE | 8.4% | ||
| ROIC | 6.11% | ||
| ROICexc | 6.63% | ||
| ROICexgc | 4145.85% | ||
| OM | 21.31% | ||
| PM (TTM) | 12.84% | ||
| GM | 60.75% | ||
| FCFM | 17.65% |
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
ROICexc(3y)6.57%
ROICexc(5y)6.04%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.5%
ROCE(5y)8.01%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y12.56%
ROICexc growth 5Y14.99%
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
F-Score6
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 5.11 | ||
| Debt/EBITDA | 3.18 | ||
| Cap/Depr | 98.15% | ||
| Cap/Sales | 2.83% | ||
| Interest Coverage | 6.65 | ||
| Cash Conversion | 84.66% | ||
| Profit Quality | 137.52% | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.78 | ||
| Altman-Z | 2.31 |
F-Score6
WACC8.15%
ROIC/WACC0.75
Cap/Depr(3y)107.06%
Cap/Depr(5y)107.33%
Cap/Sales(3y)2.94%
Cap/Sales(5y)3.03%
Profit Quality(3y)156.45%
Profit Quality(5y)128.12%
High Growth Momentum
Growth
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
EPS Next Y5.74%
EPS Next 2Y8.04%
EPS Next 3Y8.69%
EPS Next 5Y10.1%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-5.33%
Revenue Next Year-1.32%
Revenue Next 2Y1.63%
Revenue Next 3Y2.58%
Revenue Next 5Y3.76%
EBIT growth 1Y4.68%
EBIT growth 3Y5.1%
EBIT growth 5Y9.75%
EBIT Next Year11.73%
EBIT Next 3Y8.42%
EBIT Next 5Y7.85%
FCF growth 1Y12.42%
FCF growth 3Y23.3%
FCF growth 5Y29.57%
OCF growth 1Y9.57%
OCF growth 3Y19.28%
OCF growth 5Y23.96%
HALEON PLC-ADR / HLN FAQ
Can you provide the ChartMill fundamental rating for HALEON PLC-ADR?
ChartMill assigns a fundamental rating of 6 / 10 to HLN.
Can you provide the valuation status for HALEON PLC-ADR?
ChartMill assigns a valuation rating of 6 / 10 to HALEON PLC-ADR (HLN). This can be considered as Fairly Valued.
How profitable is HALEON PLC-ADR (HLN) stock?
HALEON PLC-ADR (HLN) has a profitability rating of 8 / 10.
Can you provide the PE and PB ratios for HLN stock?
The Price/Earnings (PE) ratio for HALEON PLC-ADR (HLN) is 20.08 and the Price/Book (PB) ratio is 2.06.
Can you provide the dividend sustainability for HLN stock?
The dividend rating of HALEON PLC-ADR (HLN) is 5 / 10 and the dividend payout ratio is 39.53%.